Biomarkers, Tumor

Preferred Label : Biomarkers, Tumor;

MeSH definition : Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS.;

MeSH synonym : marker, biochemical tumor; tumor marker, biological; tumor marker, biologic; tumor metabolite markers; markers, biochemical tumor; neoplasm metabolite markers; markers, neoplasm metabolite; biological tumor markers; biochemical tumor markers; metabolite marker, neoplasm; metabolite marker, tumor; metabolite markers, neoplasm; markers, biologic tumor; biologic tumor markers; biochemical tumor marker; tumor markers, biochemical; tumor markers, biologic; tumor metabolite marker; biological tumor marker; carcinogen markers; markers, carcinogen; tumor marker, biochemical; marker, biologic tumor; biologic tumor marker; marker, biological tumor; marker, neoplasm metabolite; neoplasm metabolite marker; marker, tumor metabolite; markers, biological tumor; markers, tumor metabolite; metabolite markers, tumor; Tumor Biomarkers; Tumor Markers, Biological; Tumor Biomarker; Biomarker, Tumor;

MeSH Hyperonym : markers, tumor; Tumor Markers; Biomarkers, Cancer; Cancer Biomarkers; Tumor Marker; Marker, Tumor; Cancer Biomarker; Biomarker, Cancer;

MeSH annotation : IM; coord with specific substance (IM) if pertinent; DF: TUMOR MARKERS; Manual 24.4.4.5; IM; coord with specific substance (IM) if pertinent; DF: TUMOR MARKERS; Manual 24.4.4.5;

Wikipedia link : https://en.wikipedia.org/wiki/Tumor markers;

Is substance : O;

Details

Origin ID

D014408;

UMLS CUI

C0041366;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Biochemical tumor marker (substance) [SNOMED CT concept]
- Tumor Marker [NCIt concept]
- Tumor marker [LOINC component]
- metabolite or marker of neoplasm, nos [SNOMED Notion]
- tumor markers [medical devices type]
Indexing information
- 114 kDa MAR-binding protein, human [MeSH Supplementary Concept]
- 2-6 sialyl le(a) antigen [MeSH Supplementary Concept]
- 2G3 antigen [MeSH Supplementary Concept]
- 2H6 antigen, human [MeSH Supplementary Concept]
- 4C5 monoclonal antibody [MeSH Supplementary Concept]
- 8-hexylaminoadenosine-3',5'-cyclic monophosphate [MeSH Supplementary Concept]
- ALPI protein, human [MeSH Supplementary Concept]
- APOD protein, human [MeSH Supplementary Concept]
- ARID4B protein, human [MeSH Supplementary Concept]
- AZGP1 protein, human [MeSH Supplementary Concept]
- B protein (neoplasm) [MeSH Supplementary Concept]
- B305D-C protein, human [MeSH Supplementary Concept]
- B8.7 antigen, human [MeSH Supplementary Concept]
- BCA 225 protein, human [MeSH Supplementary Concept]
- BPH-associated protein P25-26 [MeSH Supplementary Concept]
- BPIFA1 protein, human [MeSH Supplementary Concept]
- BW 495-36 protein, human [MeSH Supplementary Concept]
- CA 195 antigen [MeSH Supplementary Concept]
- CA 27-29 antigen [MeSH Supplementary Concept]
- CA54-61 protein, human [MeSH Supplementary Concept]
- CA9 protein, human [MeSH Supplementary Concept]
- CAGE1 protein, human [MeSH Supplementary Concept]
- CAP2 protein, zebrafish [MeSH Supplementary Concept]
- CASA antigen [MeSH Supplementary Concept]
- CASC8 lncRNA, human [MeSH Supplementary Concept]
- CCDC7 protein, human [MeSH Supplementary Concept]
- CDR1 protein, human [MeSH Supplementary Concept]
- CHMP2A protein, human [MeSH Supplementary Concept]
- CIP2A protein, human [MeSH Supplementary Concept]
- CL-5A antigen, human [MeSH Supplementary Concept]
- CLVS1 protein, human [MeSH Supplementary Concept]
- CRxA-01 antibody, human [MeSH Supplementary Concept]
- CTAGE1 protein, human [MeSH Supplementary Concept]
- Ca1 antibody [MeSH Supplementary Concept]
- Cdr1 protein, mouse [MeSH Supplementary Concept]
- Cep290 protein, human [MeSH Supplementary Concept]
- DLGAP5 protein, human [MeSH Supplementary Concept]
- DU-PAN-2 antigen, human [MeSH Supplementary Concept]
- EEF1A1 protein, human [MeSH Supplementary Concept]
- EM66 peptide [MeSH Supplementary Concept]
- ERD5 protein, human [MeSH Supplementary Concept]
- Epstein-Barr virus phosphoprotein pp58 [MeSH Supplementary Concept]
- FAM163A protein, human [MeSH Supplementary Concept]
- FAM83A protein, human [MeSH Supplementary Concept]
- FAM83B protein, human [MeSH Supplementary Concept]
- FBXL17 protein, human [MeSH Supplementary Concept]
- FSTL5 protein, human [MeSH Supplementary Concept]
- GBP2 protein, human [MeSH Supplementary Concept]
- GLDN protein, human [MeSH Supplementary Concept]
- HBA-71 tumor antigen [MeSH Supplementary Concept]
- HPR protein, human [MeSH Supplementary Concept]
- HSAJ2425 protein, human [MeSH Supplementary Concept]
- HSPA9 protein, human [MeSH Supplementary Concept]
- HSPB1 protein, human [MeSH Supplementary Concept]
- Hsbp1 protein, mouse [MeSH Supplementary Concept]
- Hspb1 protein, rat [MeSH Supplementary Concept]
- IGDCC4 protein, human [MeSH Supplementary Concept]
- Imacis-1 [MeSH Supplementary Concept]
- KIR3DL2 protein, human [MeSH Supplementary Concept]
- KLK13 protein, human [MeSH Supplementary Concept]
- KMO1 antigen [MeSH Supplementary Concept]
- LK26 antigen [MeSH Supplementary Concept]
- MALAT1 long non-coding RNA, human [MeSH Supplementary Concept]
- MECT1-MAML2 fusion protein, human [MeSH Supplementary Concept]
- MELTF protein, human [MeSH Supplementary Concept]
- MIEN1 protein, human [MeSH Supplementary Concept]
- MIRN125 microRNA, human [MeSH Supplementary Concept]
- MKW antigen [MeSH Supplementary Concept]
- MLL-AF4 fusion protein, human [MeSH Supplementary Concept]
- MUC12 protein, human [MeSH Supplementary Concept]
- Ma2 antigen [MeSH Supplementary Concept]
- Malat1 long non-coding RNA, mouse [MeSH Supplementary Concept]
- OR51E1 protein, human [MeSH Supplementary Concept]
- OVX1 antigen [MeSH Supplementary Concept]
- PAM4 protein, human [MeSH Supplementary Concept]
- PCA-1 antigen, human [MeSH Supplementary Concept]
- PIK3CA protein, human [MeSH Supplementary Concept]
- PIP protein, human [MeSH Supplementary Concept]
- PLXDC1 protein, human [MeSH Supplementary Concept]
- PLXDC2 protein, human [MeSH Supplementary Concept]
- PPP2R5C protein, human [MeSH Supplementary Concept]
- PR92 antigen, human [MeSH Supplementary Concept]
- Plxdc1 protein, rat [MeSH Supplementary Concept]
- Pvr protein, rat [MeSH Supplementary Concept]
- RM2 antigen, human [MeSH Supplementary Concept]
- RNA-proteolipid complex [MeSH Supplementary Concept]
- RS-DJ-1 antigen [MeSH Supplementary Concept]
- S100A7 protein, human [MeSH Supplementary Concept]
- S100a7a protein, mouse [MeSH Supplementary Concept]
- SFN protein, human [MeSH Supplementary Concept]
- SFTPB protein, human [MeSH Supplementary Concept]
- SMPDL3A protein, human [MeSH Supplementary Concept]
- SNC73 protein, human [MeSH Supplementary Concept]
- ST 439 antigen, human [MeSH Supplementary Concept]
- SYT-SSX fusion protein [MeSH Supplementary Concept]
- TAA90K protein, human [MeSH Supplementary Concept]
- TAG 12 [MeSH Supplementary Concept]
- TMEM25 protein, human [MeSH Supplementary Concept]
- TRA-1-60 antigen, human [MeSH Supplementary Concept]
- TRA-1-81 antigen, human [MeSH Supplementary Concept]
- Tdgf1 protein, mouse [MeSH Supplementary Concept]
- Thomsen-Friedenreich antigen [MeSH Supplementary Concept]
- UCA1 RNA, human [MeSH Supplementary Concept]
- UCHL1 protein, human [MeSH Supplementary Concept]
- UCHL1 protein, rat [MeSH Supplementary Concept]
- adenoma-associated antigen glycoprotein 87, human [MeSH Supplementary Concept]
- adenosine-N(6)-diethylthioether-N'-pyridoximine 5'-phosphate [MeSH Supplementary Concept]
- antigen CYFRA21.1 [MeSH Supplementary Concept]
- aromatic amine acetyltransferase [MeSH Supplementary Concept]
- beta1-meconial antigen [MeSH Supplementary Concept]
- breast cancer-associated antigen 200, human [MeSH Supplementary Concept]
- colon cancer-specific antigen 2, human [MeSH Supplementary Concept]
- colon-specific antigen [MeSH Supplementary Concept]
- common chronic lymphatic leukemia antigen gp69, human [MeSH Supplementary Concept]
- common myelogenous leukemia-associated antigen [MeSH Supplementary Concept]
- cora antigen [MeSH Supplementary Concept]
- cytoplasmic linker protein 170 [MeSH Supplementary Concept]
- deltaIK17 antigen [MeSH Supplementary Concept]
- dimeric le(a) antigen, human [MeSH Supplementary Concept]
- epithelial membrane protein-1 [MeSH Supplementary Concept]
- estrogen-induced secretory glycoprotein, mouse [MeSH Supplementary Concept]
- exposed proliferation antigen 210 [MeSH Supplementary Concept]
- fibroblast activation protein alpha [MeSH Supplementary Concept]
- ganglio-N-triaosylceramide [MeSH Supplementary Concept]
- gastrointestinal tract acid-446 [MeSH Supplementary Concept]
- germ-cell AP isoenzyme [MeSH Supplementary Concept]
- glycerol 2-phosphoglycerol [MeSH Supplementary Concept]
- glycoprotein BCA 225 [MeSH Supplementary Concept]
- gp240 glycoprotein, human [MeSH Supplementary Concept]
- immunosuppressive acidic protein [MeSH Supplementary Concept]
- integrin alphaEbeta7 [MeSH Supplementary Concept]
- integrin alphaupsilonbeta6 [MeSH Supplementary Concept]
- lewis(a)-lewis(x) [MeSH Supplementary Concept]
- lipid-associated sialic acid [MeSH Supplementary Concept]
- lung cancer-associated protein, LCAP [MeSH Supplementary Concept]
- mammary serum antigen, human [MeSH Supplementary Concept]
- manserin protein, human [MeSH Supplementary Concept]
- melanoma-derived CT16 cancer testis antigen, human [MeSH Supplementary Concept]
- metanestin protein, human [MeSH Supplementary Concept]
- monoclonal antibody D2-40 [MeSH Supplementary Concept]
- nuclear matrix protein 22 [MeSH Supplementary Concept]
- oncofetal antigens [MeSH Supplementary Concept]
- oncolipids [MeSH Supplementary Concept]
- p65 oncofetal mRNA transport protein, rat [MeSH Supplementary Concept]
- pancreatic associated antigen, SPan-1 [MeSH Supplementary Concept]
- placental protein 11 [MeSH Supplementary Concept]
- pro-gastrin-releasing peptide (31-98) [MeSH Supplementary Concept]
- prostein [MeSH Supplementary Concept]
- proto-oncogene proteins c-fgr [MeSH Supplementary Concept]
- sialosyl-Tn antigen [MeSH Supplementary Concept]
- sialyl le(a) ganglioside [MeSH Supplementary Concept]
- squamous cell carcinoma-related antigen [MeSH Supplementary Concept]
- tetranectin [MeSH Supplementary Concept]
- tissue polypeptide specific antigen [MeSH Supplementary Concept]
- trophoblastic glycoprotein 5T4, human [MeSH Supplementary Concept]
- tumor-associated antigen 43-9F [MeSH Supplementary Concept]
- tumor-associated antigen 72 [MeSH Supplementary Concept]
- urinary gonadotropin fragment [MeSH Supplementary Concept]
- urine S 100 protein, alpha subunit, human [MeSH Supplementary Concept]
- zinc glycinate [MeSH Supplementary Concept]
Metaterm(s)
- oncology [CISMeF Metaterm]
Record concept(s)
- Biomarkers, Tumor [MeSH concept]
- markers, tumor [MeSH concept]
Related MeSH Supplementary Concept(s)
- ANTXR1 protein, mouse [MeSH Supplementary Concept]
- Adnab-9 [MeSH Supplementary Concept]
- BAT26 microsatellite DNA [MeSH Supplementary Concept]
- BLCA-4 protein, human [MeSH Supplementary Concept]
- CA8 protein, human [MeSH Supplementary Concept]
- CAR-3 antigen [MeSH Supplementary Concept]
- CST7 protein, human [MeSH Supplementary Concept]
- Car8 protein, mouse [MeSH Supplementary Concept]
- ENO1 protein, human [MeSH Supplementary Concept]
- GSDMC protein, human [MeSH Supplementary Concept]
- HBME-1 antigen [MeSH Supplementary Concept]
- LA-1 oncogene protein, human [MeSH Supplementary Concept]
- LGALS3BP protein, human [MeSH Supplementary Concept]
- NIBAN1 protein, human [MeSH Supplementary Concept]
- PHF20 protein, human [MeSH Supplementary Concept]
- PNL2 tumor biomarker [MeSH Supplementary Concept]
- PTOV1 protein, human [MeSH Supplementary Concept]
- RFLNA protein, human [MeSH Supplementary Concept]
- SFN protein, human [MeSH Supplementary Concept]
- TCTP protein, drosophila [MeSH Supplementary Concept]
- VWA2 protein, human [MeSH Supplementary Concept]
- Vwa2 protein, mouse [MeSH Supplementary Concept]
- bladder tumor-associated antigen [MeSH Supplementary Concept]
- human epithelial antigen-125 [MeSH Supplementary Concept]
- trophoblastic beta 1-glycoprotein receptor, human [MeSH Supplementary Concept]
See also
- neoplasm proteins [MeSH Descriptor]
See also (suggested by CISMeF)
- Biomarkers [MeSH Descriptor]
Semantic type(s)
- Biologically Active Substance [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients